Table 73-1.
Bacterial Vaccines Currently Licensed in the United States as of April 2012
| Vaccine | Manufacturer* |
|---|---|
| Anthrax vaccine, adsorbed | 6 |
| Bacille Calmette-Guérin (BCG) vaccine | 11 |
| Diphtheria and tetanus toxoids adsorbed | 1 |
| Diphtheria and tetanus toxoids and acellular pertussis vaccine, adsorbed | 1†, 2, 7 |
| Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined | 7 |
| Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine | 7 |
| Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated Poliovirus and Haemophilus b conjugate (tetanus toxoid conjugate) vaccine | 2 |
| Tetanus and diphtheria toxoids, adsorbed | 4 |
| Tetanus and diphtheria toxoids, adsorbed for adult use | 1 |
| Tetanus toxoid | 1 |
| Tetanus toxoid, adsorbed | 1 |
| Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed | 2, 7 |
| Haemophilus b conjugate vaccine (meningococcal protein conjugate) | 5 |
| Haemophilus b conjugate vaccine (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine | 5 |
| Haemophilus b conjugate vaccine (tetanus toxoid conjugate) | 7, 8 |
| Meningococcal (groups A, C, Y, and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | 10 |
| Meningococcal polysaccharide vaccine, groups A, C, Y, W135 combined | 1 |
| Meningococcal polysaccharide (serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine | 1 |
| Pneumococcal vaccine, polyvalent | 5 |
| Pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein) | 3 |
| Pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) | 3 |
| Typhoid vaccine, live oral, Ty21a | 9 |
| Typhoid Vi polysaccharide vaccine | 8 |
1, Sanofi Pasteur, Inc.; 2, Sanofi Pasteur, Ltd.; 3, Wyeth, a subsidiary of Pfizer; 4, Massachusetts Public Health Biological Laboratories; 5, Merck & Co., Inc.; 6, Emergent Biodefense Operations Lansing, Inc.; 7, GlaxoSmithKline Biologicals; 8, Sanofi Pasteur S.A.; 9, Berna Biotech; 10, Novartis Vaccines and Diagnostics, Inc.; 11, Organon Teknika Corporation LLC.
†
License for the pertussis component of this product is held by the Research Foundation for Microbial Diseases of Osaka University (Aventis Pasteur Laboratories, Inc.).